XML 124 R95.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity / (Deficit) (Tables) (FaceBank Group, Inc. Pre-Merger)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Schedule of Stock Option Activity  

A summary of activity under the Plan for the nine months ended September 30, 2020 is as follows (in thousands, except share and per share amounts):

 

    Number of Shares     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average
Remaining
Contractual Life
(in years)		  
Outstanding as of December 31, 2019     16,667     $ 28.20     $                       -       7.3  
Options assumed from Merger     8,051,098     $ 1.31                  
Granted     7,141,899     $ 8.79                  
Exercised     (226,740 )   $ 1.43                  
Forfeited or expired     (389,008 )   $ 0.83                  
Outstanding as of September 30, 2020     14,593,916     $ 4.99     $ 61,234       8.2  
                                 
Options vested and exercisable as of September 30, 2020     6,081,567     $ 2.01     $ 42,736       6.9  
  
Summary of Fair Value of Options Granted  

The following was used in determining the fair value of stock options granted during the three months and nine months ended September 30, 2020:

 

    For the Three Months
Ended September 30,
2020		     For the Nine Months
Ended September 30,
2020		  
Dividend yield     -       -  
Expected price volatility     45 %     45% - 57 %
Risk free interest rate     0.23% - 0.38 %     0.23% - 0.58 %
Expected term     5.3 - 6.1       5.3 - 6.1  

  
Summary of Outstanding Warrants Activity  

A summary of the Company’s outstanding warrants as of September 30, 2020 are presented below (in thousands, except share and per share amounts):

 

    Number of Warrants     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average
Remaining
Contractual Life
 (in years)		  
Outstanding as of December 31, 2019     200,007     $ 13.31     $ -       0.2  
Issued     9,538,526     $ 6.62     $ 23,119       1.7  
Expired     (200,000 )   $ -     $ -       -  
Outstanding as of September 30, 2020     9,538,533     $ 5.80     $ 32,670       2.6  
Warrants exercisable as of September 30, 2020     9,538,533     $ 5.80     $ 32,670       2.6  
  
FaceBank Group, Inc Pre-Merger [Member]      
Schedule of Stock Option Activity

The following reflects the stock option activity for the three months ended March 31, 2020:

 

    Number of Shares     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of December 31, 2019     16,667     $ 28.20     $ -       8.1  
Granted     280,000     $ 7.20     $ 322,000       4.7  
Outstanding as of March 31, 2020     296,667     $ 8.38     $ 322,000       4.9  
                                 
Options vested and exercisable as of March 31, 2020     296,667     $ 8.38     $ 322,000       4.9  

    
Summary of Fair Value of Options Granted    

The fair value of options granted during the year ended December 31, 2018 were estimated using the following weighted-average assumptions:

 

    Year ended December 31, 2018  
Exercise price   $ 28.20  
Expected stock price volatility     222  
Risk-free rate of interest     2.78  
Term (years)     10.0  
         
Summary of Options Under Employee Stock Option Plan    

A summary of option activity under the Company’s employee stock option plan for years ended December 31, 2018 and 2019 are presented below:

 

      Number of Shares     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of December 31, 2017       -     $ -     $       -       -  
Granted       16,667       28.20       -       9.1  
Outstanding as of December 31, 2018       16,667     $ 28.20     $ -       9.1  
Outstanding as of December 31, 2019       16,667     $ 28.20     $ -       8.1  
Options vested and exercisable as of December 31, 2019       16,667     $ 28.20     $ -       8.1  
Summary of Outstanding Warrants Activity

A summary of the Company’s outstanding warrants as of March 31, 2020 are presented below:

 

    Number of Warrants     Weighted Average
Exercise Price		     Total Intrinsic Value  
Outstanding as of December 31, 2019     200,007     $ 12.15     $ -  
Issued     3,411,349     $ 5.11     $ 11,038,616  
Expired     (200,000 )   $ -     $ -  
Outstanding as of March 31, 2020     3,411,356     $ 5.16     $ 11,038,616  
Warrants exercisable as of March 31, 2020     3,411,356     $ 5.16     $ 11,038,616  

  

A summary of the Company’s outstanding warrants as of December 31, 2019 and 2018 are presented below:

 

      Number of Warrants     Weighted Average
Exercise Price		     Total Intrinsic Value     Weighted Average Remaining Contractual Life
 (in years)		  
Outstanding as of December 31, 2017       3,015     $ 15.00     $        -       4.7  
Exercised       (3,008 )     15.00               -  
Outstanding as of December 31, 2018**       7     $ 24,000.00     $ -       2.9  
Issued       200,000       11.31       -       0.2  
Outstanding as of December 31, 2019       200,007     $ 12.15     $ -       0.2  
Warrants exercisable as of December 31, 2019       200,007     $ 12.15     $ -       0.2  

 

** The warrants outstanding as of December 31, 2018 had an original exercise price of $0.80. In January 2017, the Company executed a 1-for-10,000 reverse split, that resulted in an exercise price of $800. Following the 1 for 30 reverse split in February 2019, the exercise price is currently $24,000 per share.